SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences - Quaterly Results

12 Aug 2024 Evaluate
The revenue zoomed 12.91% to Rs. 1819.12 millions for the quarter ended June 2024 as compared to Rs. 1611.12 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2024 is Rs. -136.79 millions as compared to Net Profit of Rs. 57.80 millions of corresponding quarter ended June 2023The company reported a degrowth in operating Profit to 87.14 millions from 311.06 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1819.12 1611.12 12.91 1819.12 1611.12 12.91 7732.62 7894.36 -2.05
Other Income 17.80 60.12 -70.39 17.80 60.12 -70.39 188.83 288.32 -34.51
PBIDT 87.14 311.06 -71.99 87.14 311.06 -71.99 460.13 1563.90 -70.58
Interest 136.17 120.47 13.03 136.17 120.47 13.03 543.26 569.42 -4.59
PBDT -49.03 190.59 -125.73 -49.03 190.59 -125.73 -102.41 994.48 -110.30
Depreciation 126.93 117.97 7.60 126.93 117.97 7.60 493.90 328.21 50.48
PBT -175.96 72.62 -342.30 -175.96 72.62 -342.30 -596.31 666.27 -189.50
TAX -39.17 14.82 -364.30 -39.17 14.82 -364.30 -82.43 190.71 -143.22
Deferred Tax -1.34 -2.81 -52.31 -1.34 -2.81 -52.31 -82.43 51.51 -260.03
PAT -136.79 57.80 -336.66 -136.79 57.80 -336.66 -513.88 475.56 -208.06
Equity 167.50 167.35 0.09 167.50 167.35 0.09 167.47 157.09 6.61
PBIDTM(%) 4.79 19.31 -75.19 4.79 19.31 -75.19 5.95 19.81 -69.96

Camlin Fine Sciences Share Price

126.00 -0.97 (-0.76%)
04-May-2026 09:09 View Price Chart
Peers
Company Name CMP
BASF India 3691.95
Tata Chemicals 820.30
SRF 2524.90
Pidilite Inds. 1379.95
Deepak Nitrite 1740.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×